Alia Abdel-Razeq, the Chief Operating Officer at CellSave Arabia, stands as a prominent figurehead in the forefront of the stem cell and regenerative medicine revolution in the Middle East. She has a background rooted in chemical and pharmaceutical engineering, complemented by extensive experience in healthcare management and research. Under Alia’s insightful leadership, CellSave Arabia has expanded its offerings to cater comprehensively to the diverse needs of individuals and institutions. Notably, a groundbreaking addition is newborn stem cell storage for longevity purposes, empowering families with future-use options with stem cells and stem cell-derived exosomes. Furthermore, CellSave Arabia is pioneering stem cell therapy services, revolutionizing treatments for conditions such as autoimmune disorders, heart disease, neurological ailments, regenerative medicine, and more.